These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 21546935

  • 21. Changes in oxidative stress markers and cardiometabolic risk factors among Roux-en-Y gastric bypass patients after 3- and 12-months postsurgery follow-up.
    Pinto SL, Juvanhol LL, Licursi de Oliveira L, Clemente RC, Bressan J.
    Surg Obes Relat Dis; 2019 Oct; 15(10):1738-1745. PubMed ID: 31495634
    [Abstract] [Full Text] [Related]

  • 22. [Comparison of 1-year outcomes between Roux-en-Y gastric bypass and sleeve gastrectomy with Roux-en-Y duodenojejunal bypass in the patients of obesity with type 2 diabetes mellitus].
    Liang H, Si YM, Lin SB, Shen JJ, Guan W.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Nov 25; 26(11):1051-1057. PubMed ID: 37974350
    [Abstract] [Full Text] [Related]

  • 23. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.
    Kashyap SR, Daud S, Kelly KR, Gastaldelli A, Win H, Brethauer S, Kirwan JP, Schauer PR.
    Int J Obes (Lond); 2010 Mar 25; 34(3):462-71. PubMed ID: 20029383
    [Abstract] [Full Text] [Related]

  • 24. Changes in inflammation, oxidative stress and adipokines following bariatric surgery among adolescents with severe obesity.
    Kelly AS, Ryder JR, Marlatt KL, Rudser KD, Jenkins T, Inge TH.
    Int J Obes (Lond); 2016 Feb 25; 40(2):275-80. PubMed ID: 26315843
    [Abstract] [Full Text] [Related]

  • 25. Laparoscopic Roux-En-Y Gastric Bypass Improves Lipid Profile and Decreases Cardiovascular Risk: a 5-Year Longitudinal Cohort Study of 1048 Patients.
    Gero D, Favre L, Allemann P, Fournier P, Demartines N, Suter M.
    Obes Surg; 2018 Mar 25; 28(3):805-811. PubMed ID: 28971303
    [Abstract] [Full Text] [Related]

  • 26. Relationship among physical activity, sedentary behaviors, and cardiometabolic risk factors during gastric bypass surgery-induced weight loss.
    Wefers JF, Woodlief TL, Carnero EA, Helbling NL, Anthony SJ, Dubis GS, Jakicic JM, Houmard JA, Goodpaster BH, Coen PM.
    Surg Obes Relat Dis; 2017 Feb 25; 13(2):210-219. PubMed ID: 27789136
    [Abstract] [Full Text] [Related]

  • 27. Plasma ceramides are elevated in female children and adolescents with type 2 diabetes.
    Lopez X, Goldfine AB, Holland WL, Gordillo R, Scherer PE.
    J Pediatr Endocrinol Metab; 2013 Feb 25; 26(9-10):995-8. PubMed ID: 23612696
    [Abstract] [Full Text] [Related]

  • 28. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2.
    Lee WJ, Chong K, Chen CY, Chen SC, Lee YC, Ser KH, Chuang LM.
    Obes Surg; 2011 Jul 25; 21(7):889-95. PubMed ID: 21499957
    [Abstract] [Full Text] [Related]

  • 29. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.
    Malin SK, Bena J, Abood B, Pothier CE, Bhatt DL, Nissen S, Brethauer SA, Schauer PR, Kirwan JP, Kashyap SR.
    Diabetes Obes Metab; 2014 Dec 25; 16(12):1230-8. PubMed ID: 25132119
    [Abstract] [Full Text] [Related]

  • 30. Gastric bypass simultaneously improves adipose tissue function and insulin-dependent type 2 diabetes mellitus.
    Billeter AT, Vittas S, Israel B, Scheurlen KM, Hidmark A, Fleming TH, Kopf S, Büchler MW, Müller-Stich BP.
    Langenbecks Arch Surg; 2017 Sep 25; 402(6):901-910. PubMed ID: 28691147
    [Abstract] [Full Text] [Related]

  • 31. Ceramide concentrations in liver, plasma, and very low-density lipoproteins of humans with severe obesity.
    Lytle KA, Chung JO, Bush NC, Triay JM, Jensen MD.
    Lipids; 2023 May 25; 58(3):107-115. PubMed ID: 36849669
    [Abstract] [Full Text] [Related]

  • 32. Roux-en-Y gastric bypass decreases serum inflammatory markers and cardiovascular risk factors in obese diabetics.
    Rossi I, Omotosho P, Poirier J, Spagnoli A, Torquati A.
    Surgery; 2021 Mar 25; 169(3):539-542. PubMed ID: 33168209
    [Abstract] [Full Text] [Related]

  • 33. Effects of Roux-en-Y gastric bypass or diabetes support and education on insulin sensitivity and insulin secretion in morbidly obese patients with type 2 diabetes.
    Khoo CM, Chen J, Pamuklar Z, Torquati A.
    Ann Surg; 2014 Mar 25; 259(3):494-501. PubMed ID: 23732262
    [Abstract] [Full Text] [Related]

  • 34. Metabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes.
    Feng W, Yin T, Chu X, Shan X, Jiang C, Wang Y, Qian Y, Zhu D, Sun X, Bi Y.
    Diabetes Metab Res Rev; 2019 Jul 25; 35(5):e3138. PubMed ID: 30740871
    [Abstract] [Full Text] [Related]

  • 35. Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery.
    Trakhtenbroit MA, Leichman JG, Algahim MF, Miller CC, Moody FG, Lux TR, Taegtmeyer H.
    Am J Med; 2009 May 25; 122(5):435-42. PubMed ID: 19375553
    [Abstract] [Full Text] [Related]

  • 36. [Efficacy of modified Roux-en-Y gastric bypass in the treatment of non-obese type 2 diabetes mellitus:one year follow-up].
    Chen YF, Yang F, Yang YL, Wu N, Zheng ZG, Li XL, Yang B, Wang L, Chen Y, Lian HL, Song B, Xue YJ, Cai HW, Dou KF, Chen Y.
    Zhonghua Wai Ke Za Zhi; 2012 Oct 25; 50(10):879-82. PubMed ID: 23302455
    [Abstract] [Full Text] [Related]

  • 37. Short-term Effects of Laparoscopic Adjustable Gastric Banding Versus Roux-en-Y Gastric Bypass.
    Gastaldelli A, Iaconelli A, Gaggini M, Magnone MC, Veneziani A, Rubino F, Mingrone G.
    Diabetes Care; 2016 Nov 25; 39(11):1925-1931. PubMed ID: 27573937
    [Abstract] [Full Text] [Related]

  • 38. Association between Plasmatic Ceramides Profile and AST/ALT Ratio: C14:0 Ceramide as Predictor of Hepatic Steatosis in Adolescents Independently of Obesity.
    Maldonado-Hernández J, Saldaña-Dávila GE, Piña-Aguero MI, Núñez-García BA, López-Alarcón MG.
    Can J Gastroenterol Hepatol; 2017 Nov 25; 2017():3689375. PubMed ID: 28634575
    [Abstract] [Full Text] [Related]

  • 39. Roux-en-Y gastric bypass restores islet function and morphology independent of body weight in ZDF rats.
    Mosinski JD, Aminian A, Axelrod CL, Batayyah E, Romero-Talamas H, Daigle C, Mulya A, Scelsi A, Schauer PR, Brethauer SA, Kirwan JP.
    Am J Physiol Endocrinol Metab; 2021 Feb 01; 320(2):E392-E398. PubMed ID: 33427046
    [Abstract] [Full Text] [Related]

  • 40. Glycemic control and BMI changes after endoscopic implantation of a duodenojejunal bypass liner compared with laparoscopic Roux-en-Y gastric bypass surgery: a propensity score matching analysis.
    Günthert SJ, Aksan A, Schröder O, Meyer G, Hausmann J, Stein J, Stier C.
    Surg Endosc; 2022 Aug 01; 36(8):5979-5985. PubMed ID: 35378626
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.